Dec 07, 2021 06:19 PM (GMT+8) · EqualOcean
Cailian, Dec. 7 (Xinhua) -- Fangsheng pharmaceutical announced that during the implementation of the reduction plan, shareholder Jincheng reduced 7871097 shares through passive centralized bidding and block trading respectively from June 29, 2021 to October 29, 2021, accounting for 1.83% of the total share capital of the company. The implementation time of the share reduction plan has expired.